The people building genome-driven AMR care.
A clinical and computational team building a research prototype.
Our scientists, engineers, and clinicians are building precision AMR diagnostics.
Different expertise. One system. One company. BactoAI is a multidisciplinary team building one AMR intelligence platform. The product, models, and technology belong to the company, and each of us leads a defined part of it.

Biotechnology researcher at Kenyatta University with hands-on analytical experience from a Kenya Bureau of Standards attachment in gravimetry, titrimetry, spectroscopy, and related laboratory methods. An alumnus of the NextGen Antimicrobial Stewards Initiative and 2nd-place finisher at Kenyatta University's Research in Science bootcamp, where BactoAI was first pitched.
Leads BactoAI's vision, scientific direction, and strategic growth, representing the company with hospitals, universities, funders, and antimicrobial stewardship networks across East Africa.

Software engineer responsible for BactoAI's technology infrastructure and product development.
Leads the engineering architecture, cloud systems, and development workflows that transform BactoAI's scientific models and data pipelines into reliable, scalable software products.

Electrical engineer specialising in applied machine learning and predictive analytics.
Leads the development, training, evaluation, and optimisation of BactoAI's machine-learning systems, working closely with the wider team to translate scientific and clinical requirements into reliable predictive tools.

Leads BactoAI's day-to-day operations, pilot coordination, project execution, and organisational systems.
Connects the scientific, engineering, and partnership functions to ensure that projects move efficiently from development to real-world implementation.

Kenyatta University biotechnologist with laboratory training in molecular biology, virology and bacteriology at the National Veterinary Reference Laboratory. Led grants and partnerships for the Future Researchers Poster Summit.
Leads BactoAI's grant applications and builds partnerships with funders, hospitals and research institutions.
Advisors & Partners
Recognised through Kenya and East Africa's innovation ecosystem
Developed through competitive innovation programmes in Kenya and East Africa, and recognised for translational health-tech impacts
Let's build the AMR response of the next decade together.
We work with hospitals, sequencing providers, public-health agencies and academic groups. Tell us about your work and we'll respond within 2 business days.
- · Access to our validation pipeline
- · Co-authored clinical studies
- · Custom AMR reports for your isolates
- · Deployment support in low-resource labs
Join our clinical and research validation cohort.
We are seeking laboratories, hospitals and research groups to help validate BactoAI against real-world isolates.
Hospital & clinical labs
Compare BactoAI predictions with your existing susceptibility testing for meropenem, ciprofloxacin and cefotaxime.
Public health & surveillance
Explore genome-based AMR screening alongside your regional sequencing and surveillance work.
Academic & genomic research
Collaborate on validation studies and model evaluation using locally relevant bacterial isolates.
What pilot sites receive
- A shared validation protocol agreed before work begins
- Agreement analysis against your own laboratory results
- Technical onboarding for your team
- A joint review of pilot findings
From prototype to regional platform.
Represented BactoAI at Kenyatta University's startup pitch showcase, with coverage in print and on BIK's channels.
Working AI pipeline with initial antibiotic models.
Secure, scalable, browser-based platform.
Deployments with clinical partners in East Africa.
Prospective studies on real clinical isolates.
General availability for laboratories and hospitals.
Regional rollout & AMR surveillance partnerships.
